Separate indirect from direct design evidence (SIDDE)

Fixed effects model: 

            comparison k  nma direct indir. RoR z p-value
      BZD-long:placebo 1 2.80   2.80      .   . .       .
  BZD-long:seltorexant 0 6.00      .   6.00   . .       .
     BZD-long:zolpidem 0 1.40      .   1.40   . .       .
    BZD-long:zopiclone 1 1.00   1.00      .   . .       .
   seltorexant:placebo 1 0.47   0.33      .   . .       .
      zolpidem:placebo 2 2.00   2.07      .   . .       .
     zopiclone:placebo 1 2.80   2.80      .   . .       .
  seltorexant:zolpidem 1 0.23   0.33      .   . .       .
 seltorexant:zopiclone 0 0.17      .   0.17   . .       .
    zolpidem:zopiclone 0 0.71      .   0.71   . .       .

Legend:
 comparison - Treatment comparison
 k          - Number of studies providing direct evidence
 nma        - Estimated treatment effect (OR) in network meta-analysis
 direct     - Estimated treatment effect (OR) derived from direct evidence
 indir.     - Estimated treatment effect (OR) derived from indirect evidence
 RoR        - Ratio of Ratios (direct versus indirect)
 z          - z-value of test for disagreement (direct versus indirect)
 p-value    - p-value of test for disagreement (direct versus indirect)
[1] "Percent of comparisons where there is some evidence (p-value<0.05) of disagreement between direct and indirect sources: NaN. (0 out of 0 comparisons)."
[1] "File created by E. G. Ostinelli on 2022-01-02"
